Medicinova to Support Nih-Funded Expanded Access Clinical Trial to Evaluate Mn166 (Ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
美第奇新星生物技術將支持NIH資助的擴展接觸臨床試驗,評估Mn166(易布地拉斯特)用於肌萎縮側索硬化症(ALS)
Medicinova to Support Nih-Funded Expanded Access Clinical Trial to Evaluate Mn166 (Ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
美第奇新星生物技術將支持NIH資助的擴展接觸臨床試驗,評估Mn166(易布地拉斯特)用於肌萎縮側索硬化症(ALS)
譯文內容由第三人軟體翻譯。